FDA Reasserts Dura Mater Device Status During Interim Preceding GTPs
This article was originally published in The Gray Sheet
Executive Summary
FDA is moving forward with rules establishing human dura mater as a Class II medical device before the agency issues guidelines transitioning the product into the purview of tissue regulation